Usability of the Regen Gait Therapy Robot in Healthy Adults

April 16, 2026 updated by: Hao-Yuan Hsiao, University of Texas at Austin
Regen is a robot-assisted device designed to help therapists and improve the quality of treatment. It works by replicating the movement of the therapist and providing assistance as needed for the patient. This study aims to assess the safety, feasibility, usability, and ability to Regen to replicate the movement pattern of therapist in young healthy adults during treadmill walking.

Study Overview

Status

Recruiting

Detailed Description

Physical therapy, despite its effectiveness, is a physically demanding profession that requires moderate to high physical and psychological work demands. A single session typically lasts close to an hour per patient, with a substantial portion dedicated to hands-on rehabilitation therapy, excluding assessment. Long sessions, repetitive manual motions, and awkward postures contribute to fatigue, risk of musculoskeletal strain, and limited treatment duration.

One of such physically demanding tasks in rehabilitation is gait training, which often requires therapists to provide continuous manual assistance to a patient's lower limbs during treadmill walking or overground training. This repetitive, non-ergonomic work not only accelerates therapist fatigue and low back pain but also restricts the number of gait cycles that can be practiced, thereby limiting patient outcomes. These challenges create a growing need for robotic technology that can share the physical workload while maintaining therapy quality.

Rehabilitation robotic technology ranges from exoskeletons to end-effector-based assisted training devices. These provide precision, repeatability, and adaptability beyond traditional therapy methods, while also providing sensory and motor feedback. Despite these advantages, current robotic devices still face significant barriers to widespread adoption. Most rehabilitation robots either provide fixed-repetitive motions, work on just one joint, or require extensive pre-programming, which limits adaptability and versatility to individual patient needs. Further, high equipment costs, the need for specialized staff training, and required adaptations to clinical infrastructure often limit their accessibility and scalability.

Regen offers a potential solution to these gaps. Regen is a medical robotic technology aimed at improving the strength and mobility of patients. This device consists of a human-interactive robot arm that connects patients via an arm or leg brace, providing therapeutic motions to patients. It works by replicating therapist-guided movements, extending therapy duration, and ensuring consistent motion delivery. Regen is unique in its "assist-as-needed" capability. This allows the therapist to directly teach and calibrate new trajectories for each user, set repetitions, and then run based on the patient's abilities. This adaptability not only supports patient progression but also enhances motivation for the patient. Thus, the system is more responsive to the real-world variability of therapy sessions.

Before such systems can be brought into clinical practice, it is essential to evaluate usability and validity. Usability assesses whether the system is acceptable, safe, and easy to use for both therapists and patients. Validity assesses the system's ability to accurately replicate therapeutic movement trajectories.

The primary aim of this study is to evaluate the feasibility and usability of Regen in young healthy adults. The secondary aim is to assess the validity of the device in replicating therapist-guided movement using a marker-based motion capture system. The investigators hypothesize that Regen is a safe, usable, and valid tool for delivering therapist-like rehabilitation movements.

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Texas
      • Austin, Texas, United States, 78712
        • Recruiting
        • University of Texas at Austin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Healthy study participants: adults (18-50 years) who can walk independently on a treadmill for at least 6 minutes
  2. Physical therapist (PT) with a license and experience in gait rehab (self-reported)

Exclusion Criteria:

(1) For healthy study participants:

  1. Any neurological or orthopedic condition that can affect walking (Self-reported)
  2. Uncontrolled cardiovascular or metabolic condition that can affect walking (Self-reported)
  3. Current lower-limb pain or discomfort
  4. Lower-limb surgery within the past six months
  5. On medications that may impair balance (Self-reported)
  6. Open wound in the lower limb

(2) For PT:

  1. Not having license
  2. No experience in gait rehab

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Regen-assisted gait feasibility and usability arm
Single experimental arm in which all participants complete treadmill walking under therapist-assisted and Regen-assisted conditions, to evaluate the feasibility and usability of the Regen robotic gait therapy system.
Regen is a robotic gait therapy device that learns therapist-guided movement trajectories and autonomously reproduces them.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
System Usability Scale (SUS)
Time Frame: During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
The System Usability Scale (SUS) will be used to assess the usability of the device. The SUS consists of 10 items scored on a 5-point Likert scale and converted to a total score ranging from 0 to 100, with higher scores indicating better usability.
During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
NASA Task Load Index (NASA-TLX)
Time Frame: During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
The NASA Task Load Index (NASA-TLX) will be used to assess perceived workload across six domains (mental demand, physical demand, temporal demand, performance, effort, and frustration). Scores range from 0 to 100, with higher scores indicating greater workload.
During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
Device Acceptability (Likert Scale)
Time Frame: Immediately post-task (within 10 minutes after completion, Day 1)
Participants will rate safety, comfort, ease of use, and satisfaction using 5-point Likert scale items. Higher scores indicate greater acceptability of the device.
Immediately post-task (within 10 minutes after completion, Day 1)
Qualitative Feedback on Device Usability and Safety
Time Frame: Immediately post-task (within 10 minutes after completion, Day 1)
Open-ended questions will be used to collect qualitative feedback from participants and therapists regarding device usability, safety, and overall experience.
Immediately post-task (within 10 minutes after completion, Day 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hao-Yuan Hsiao, PhD, University of Austin at Texas

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 26, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

March 26, 2026

First Submitted That Met QC Criteria

April 16, 2026

First Posted (Actual)

April 23, 2026

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 16, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00008251

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Adult Participants

Clinical Trials on Regen Rehabilitation Assistive Device

Subscribe